{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:34:25Z","timestamp":1760549665732},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T00:00:00Z","timestamp":1418688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s40292-014-0077-9","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T08:59:04Z","timestamp":1418633944000},"page":"129-134","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Relationship Between Serum Uric Acid and Electrocardiographic Alterations in a Large Sample of General Population: Data From the Brisighella Heart Study"],"prefix":"10.1007","volume":"22","author":[{"given":"Arrigo F. G.","family":"Cicero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Rosticci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Reggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Derosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Parini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Grandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"D\u2019Addato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,16]]},"reference":[{"key":"77_CR1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2741\/3950","volume":"17","author":"M Jin","year":"2012","unstructured":"Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, Yang XF. Uric acid, hyperuricemia and vascular diseases. Front Biosci. 2012;17:656\u201369.","journal-title":"Front Biosci."},{"key":"77_CR2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1586\/14779072.2014.957675","volume":"12","author":"C Borghi","year":"2014","unstructured":"Borghi C, Verardi FM, Pareo I, Bentivenga C, Cicero AF. Hyperuricemia and cardiovascular disease risk. Expert Rev Cardiovasc Ther. 2014;12:1219\u201325.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"77_CR3","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2012.12.034","volume":"111","author":"S Kivity","year":"2013","unstructured":"Kivity S, Kopel E, Maor E, Abu-Bachar F, Segev S, Sidi Y, Olchovsky D. Association of serum uric acid and cardiovascular disease in healthy adults. Am J Cardiol. 2013;111:1146\u201351.","journal-title":"Am J Cardiol."},{"key":"77_CR4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01991","volume":"425","author":"Y Shi","year":"2003","unstructured":"Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 2003;425:516\u201321.","journal-title":"Nature"},{"key":"77_CR5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood.V89.2.577","volume":"89","author":"MG Netea","year":"1997","unstructured":"Netea MG, Kullberg BJ, Blok WL, Netea RT, van der Meer JW. The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. Blood. 1997;89:577\u201382.","journal-title":"Blood"},{"issue":"6","key":"77_CR6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2459\/JCM.0b013e3283595adc","volume":"14","author":"N Katsiki","year":"2013","unstructured":"Katsiki N, Karagiannis A, Athyros VG, Mikhailidis DP. Hyperuricaemia: more than just a cause of gout? J Cardiovasc Med. 2013;14(6):397\u2013402.","journal-title":"J Cardiovasc Med."},{"key":"77_CR7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11739-012-0875-9","volume":"8","author":"AF Cicero","year":"2013","unstructured":"Cicero AF, D\u2019Addato S, Reggi A. Marchesini Reggiani G, Borghi C. Hepatic steatosis index and lipid accumulation product as middle-term predictors of incident metabolic syndrome in a large population sample: data from the Brisighella Heart Study. Intern Emerg Med. 2013;8:265\u20137.","journal-title":"Intern Emerg Med"},{"key":"77_CR8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2459\/JCM.0b013e3283516798","volume":"13","author":"AF Cicero","year":"2012","unstructured":"Cicero AF, D\u2019Addato S, Santi F, Ferroni A, Borghi C, Brisighella Heart Study. Leisure-time physical activity and cardiovascular disease mortality: the Brisighella Heart Study. J Cardiovasc Med. 2012;13:559\u201364.","journal-title":"J Cardiovasc Med"},{"key":"77_CR9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/clp.11.23","volume":"6","author":"AF Cicero","year":"2011","unstructured":"Cicero AF, Dormi A, D\u2019Addato S, Borghi C, Brisighella Heart Study Staff. From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40\u00a0years of the Brisighella Heart Study. Clin Lipidol. 2011;6:269\u201376.","journal-title":"Clin Lipidol."},{"key":"77_CR10","first-page":"69","volume":"22","author":"AF Cicero","year":"2013","unstructured":"Cicero AF, Reggi A, Tartagni E, Grandi E, D\u2019Addato S, Borghi C, Brisighella Heart Study. Dietary determinants of oxidized-low-density lipoprotein antibodies in a sample of pharmacologically untreated non-smoker subjects: data from the Brisighella heart study. Adv Clin Exp Med. 2013;22:69\u201376.","journal-title":"Adv Clin Exp Med"},{"key":"77_CR11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40292-013-0033-0","volume":"21","author":"AF Cicero","year":"2013","unstructured":"Cicero AF, Rosticci M, D\u2019Addato S, Baronio C, Grossi G, Grandi E, Borghi C, Brisighella Heart Study Group. Population health needs assessment and healthcare services use in a three years follow-up on administrative and clinical data: results from the Brisighella Heart Study. High Blood Press Cardiovasc Dis. 2013;21:45\u201351.","journal-title":"High Blood Press Cardiovasc Dis."},{"key":"77_CR12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/HJH.0b013e32834f6b11","volume":"30","author":"AF Cicero","year":"2012","unstructured":"Cicero AF, D\u2019Addato S, Veronesi M, Rosticci M, Santi F, Dormi A, Borghi C, Brisighella Heart Study Group. Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample: the Brisighella Heart Study. J Hypertens. 2012;30:492\u20136.","journal-title":"J Hypertens"},{"key":"77_CR13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"77_CR14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0038-1634798","volume":"29","author":"PM Rautaharju","year":"1990","unstructured":"Rautaharju PM, MacInnis PJ, Warren JW, Wolf HK, Rykers PM, Calhoun HP. Methodology of ECG interpretation in the Dalhousie program; NOVACODE ECG classification procedures for clinical trials and population health surveys. Methods Inf Med. 1990;29:362\u201374.","journal-title":"Methods Inf Med"},{"issue":"31","key":"77_CR15","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"2013","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Red\u00f3n J, Zanchetti A, B\u00f6hm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Members Task Force. ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;2013(31):1281\u2013357.","journal-title":"J Hypertens"},{"key":"77_CR16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00392-013-0578-x","volume":"102","author":"SL Rodrigues","year":"2013","unstructured":"Rodrigues SL, Angelo LC, Baldo MP, et al. Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study. Clin Res Cardiol. 2013;102:653\u20139.","journal-title":"Clin Res Cardiol"},{"key":"77_CR17","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","volume":"33","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Dantas EM, Barcelos AM, Pereira AC, Krieger JE, Mill JG, Writing Group on the Joint ESC\/ACCF\/AHA\/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551\u201367.","journal-title":"Eur Heart J"},{"key":"77_CR18","unstructured":"http:\/\/www.azcert.org\/medical-pros\/drug-lists\/bycategory.cfm . Last accessed 1 Sept 2014."},{"key":"77_CR19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","volume":"63","author":"PC Grayson","year":"2010","unstructured":"Grayson PC, Kim SY, Lavalley M, et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010;63:102\u201310.","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"77_CR20","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.STR.0000221716.55088.d4","volume":"37","author":"MJ Bos","year":"2006","unstructured":"Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke. 2006;37:1503\u20137.","journal-title":"Stroke"},{"key":"77_CR21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","volume":"62","author":"SY Kim","year":"2010","unstructured":"Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary artery disease: a systematic review and meta-analysis. Arthritis Care Res. 2010;62:170\u201380.","journal-title":"Arthritis Care Res."},{"key":"77_CR22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/hrt.78.2.147","volume":"78","author":"SG Wannamethee","year":"1997","unstructured":"Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart. 1997;78:147\u201353.","journal-title":"Heart"},{"issue":"3","key":"77_CR23","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.mehy.2007.06.018","volume":"70","author":"X Duan","year":"2008","unstructured":"Duan X, Ling F. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure? Med Hypotheses. 2008;70(3):578\u201381.","journal-title":"Med Hypotheses"},{"issue":"2","key":"77_CR24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10741-012-9322-2","volume":"18","author":"M Kaufman","year":"2013","unstructured":"Kaufman M, Guglin M. Uric acid in heart failure: a biomarker or therapeutic target? Heart Fail Rev. 2013;18(2):177\u201386.","journal-title":"Heart Fail Rev."},{"key":"77_CR25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000320356","volume":"48","author":"IF Schwartz","year":"2011","unstructured":"Schwartz IF, Grupper A, Chernichovski T, Grupper A, Hillel O, Engel A, Schwartz D. Hyperuricemia attenuates aortic nitric oxide generation, through inhibition of arginine transport, in rats. J Vasc Res. 2011;48:252\u201360.","journal-title":"J Vasc Res"},{"key":"77_CR26","doi-asserted-by":"crossref","first-page":"C1183","DOI":"10.1152\/ajpcell.00075.2008","volume":"295","author":"S Zharikov","year":"2008","unstructured":"Zharikov S, Krotova K, Hu H, et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol. 2008;295:C1183\u201390.","journal-title":"Am J Physiol Cell Physiol"},{"key":"77_CR27","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","volume":"41","author":"J Kanellis","year":"2003","unstructured":"Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41:1287\u201393.","journal-title":"Hypertension"},{"issue":"6","key":"77_CR28","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/HJH.0b013e328337da1d","volume":"28","author":"MA Yu","year":"2010","unstructured":"Yu MA, S\u00e1nchez-Lozada LG, Johnson RJ, Kang DH. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens. 2010;28(6):1234\u201342.","journal-title":"J Hypertens."},{"issue":"2","key":"77_CR29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HJH.0b013e3282f240bf","volume":"26","author":"DB Corry","year":"2008","unstructured":"Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 2008;26(2):269\u201375.","journal-title":"J Hypertens."},{"key":"77_CR30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/europace\/eut260","volume":"16","author":"A Nyrnes","year":"2014","unstructured":"Nyrnes A, Toft I, Nj\u00f8lstad I, Mathiesen EB, Wilsgaard T, Hansen JB, L\u00f8chen ML. Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women\u2014the Tromso Study. Europace. 2014;16:320\u20136.","journal-title":"Europace."},{"issue":"4","key":"77_CR31","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1016\/j.ijcard.2013.06.067","volume":"168","author":"TF Chao","year":"2013","unstructured":"Chao TF, Hung CL, Chen SJ, Wang KL, Chen TJ, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chen SA. The association between hyperuricemia, left atrial size and new-onset atrial fibrillation. Int J Cardiol. 2013;168(4):4027\u201332.","journal-title":"Int J Cardiol."},{"issue":"5","key":"77_CR32","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.ijcard.2012.05.071","volume":"167","author":"N H\u00f6glund","year":"2013","unstructured":"H\u00f6glund N, Andersson J, Almroth H, Tornvall P, Englund A, Rosenqvist M, Jensen SM, Boman K. The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin. Int J Cardiol. 2013;167(5):2088\u201391.","journal-title":"Int J Cardiol."},{"issue":"4","key":"77_CR33","first-page":"1395","volume":"36","author":"A Mandi\u0107","year":"2012","unstructured":"Mandi\u0107 A, Tomi\u0107 M, Petrov B, Romi\u0107 Z. Atrial fibrillation, atrioventricular blocks and bundle branch blocks in hemodialysis patients. Coll Antropol. 2012;36(4):1395\u20139.","journal-title":"Coll Antropol."}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-014-0077-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40292-014-0077-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-014-0077-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T21:53:07Z","timestamp":1717624387000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40292-014-0077-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,16]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["77"],"URL":"https:\/\/doi.org\/10.1007\/s40292-014-0077-9","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,16]]}}}